Methods Forty-nine patients with fibrotic DPLD underwent level III polysomnography. Auto-
adjusting PAP (APAP) treatment was proposed for those patients with moderate-to-severe …

Introduction Sleep-disordered breathing (SDB) is a major comorbidity in idiopathic
pulmonary fibrosis (IPF) and is associated with a poor outcome. There is a lack of …

Objective Obstructive sleep apnea (OSA) are increasingly recognized as important features
in diffuse parenchymal lung diseases (DPLDs) with differed prevalence and impact reported …

Background Very little data exists on the prevalence and impact of sleep-disordered
breathing (SDB) in patients with idiopathic pulmonary fibrosis (IPF). The aim of this study …

Study objectives The most recent idiopathic pulmonary fibrosis (IPF) guidelines include
obstructive sleep apnea (OSA) among the IPF-associated comorbidities. Furthermore, they …

Background The recent literature shows an increased incidence of obstructive sleep apnea
(OSA) in patients with idiopathic pulmonary fibrosis (IPF). On the other hand, there are no …

Background and aim Several studies reported a high prevalence of Obstructive Sleep
Apnoea (OSA) in patients with Idiopathic Pulmonary Fibrosis (IPF) or restrictive end-stage …

Background From 1984 to 2006, studies of sleep in patients with interstitial lung disease
revealed disturbed sleep, frequent nocturnal desaturations, nocturnal cough, and obstructive …

Background Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with chronic,
progressive lung fibrosis with a poor prognosis. Recent studies have reported a high …

Background and aim The frequency of obstructive sleep apnea–hypopnea syndrome
(OSAHS) in patients with idiopathic pulmonary fibrosis (IPF) remains controversial. The aim …